Symbiomix Therapeutics
Latest round
- Series A
Last raised
- May 2015
Total raised
- $41M
Investors
- 4
About Symbiomix Therapeutics
Founded in 2012 and headquartered in Newark, US, Symbiomix Therapeutics focuses on developing therapies for women's health. The company was acquired in October 2017 by Lupin Limited for USD 150 mn, which included an upfront payment of USD 50 mn and additional time-based payments.Symbiomix Therapeutics specializes in delivering innovative biopharmaceutical solutions aimed at improving women's health. Their flagship products target infectious diseases and microbiome-related conditions, developed with extensive research and testing.Symbiomix Therapeutics operates a revenue model primarily based on product sales, which are driven by the demand for effective treatments in women's health. Their primary product offerings are situated at various price points, enabling access for a broad spectrum of healthcare facilities, from small clinics to larger hospitals.Looking ahead, Symbiomix Therapeutics plans to expand its product offerings with new treatments aimed at addressing unmet needs in women's health, although specific release dates are not disclosed. Furthermore, the company targets expansion into additional markets across Europe and Asia, aiming to establish a stronger presence by 2025. The recent acquisition by Lupin Limited will support these growth initiatives, leveraging additional resources for research and development to enhance their product pipeline.
Who invested in Symbiomix Therapeutics
4 investors across 1 round
See all investors in Symbiomix Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 5, 2015
Amount
$41M
Investors
Questions about Symbiomix Therapeutics
Who invested in Symbiomix Therapeutics?
Symbiomix Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Symbiomix Therapeutics raised?
Symbiomix Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Symbiomix Therapeutics last raise money?
Symbiomix Therapeutics's most recent round on record is a Series A, in May 2015.
What does Symbiomix Therapeutics do?
Founded in 2012 and headquartered in Newark, US, Symbiomix Therapeutics focuses on developing therapies for women's health.
Where is Symbiomix Therapeutics headquartered?
Symbiomix Therapeutics is headquartered in Newark, US.
Which VCs invest in companies like Symbiomix Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Symbiomix Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Symbiomix Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.